Home >> Drugs & Therapy Perspectives, Volume 21, Number 4
Drugs & Therapy Perspectives logo Adis International logo

Publisher: Adis International

Related content
Volume 21, Number 4, April 2005

< previous issue | all issues | next issue >

Drug and Profile Reports

Adalimumab is an effective option in the treatment of patients with refractory rheumatoid arthritis
pp. 1-4(4)
Author: Adis International Limited

Anidulafungin: profile report
pp. 4-6(3)
Author: Adis International Limited

Disease Management

Hot advice for managing sunburn: symptomatic approach is best
pp. 6-9(4)
Author: Adis International Limited

Gonadotropins and gonadotropin-releasing hormone analogues are vital parts of pharmacological manipulation in assisted reproduction
pp. 10-13(4)
Author: Adis International Limited

Managing psychogenic movement disorders with a multidisciplinary approach: the best move
pp. 14-17(4)
Author: Adis International Limited

Drug Reactions and Interactions

First reports of adverse drug reactions in recent weeks
pp. 18-19(2)
Author: Adis International Limited

Careful choice of agents helps achieve safe sedation in patients with head injury
pp. 20-23(4)
Author: Adis International Limited

Practical Issues and Updates

Genetic factors have a role in the development and treatment of eating disorders
pp. 23-26(4)
Author: Adis International Limited

Product Introductions

New in the marketplace
pp. 26-26(1)
Author: Adis International Limited

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page